CN1406602A - Cinese medicine increasing leucocyte and preparation thereof - Google Patents
Cinese medicine increasing leucocyte and preparation thereof Download PDFInfo
- Publication number
- CN1406602A CN1406602A CN 01127787 CN01127787A CN1406602A CN 1406602 A CN1406602 A CN 1406602A CN 01127787 CN01127787 CN 01127787 CN 01127787 A CN01127787 A CN 01127787A CN 1406602 A CN1406602 A CN 1406602A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- chemotherapy
- ginseng
- cinese
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for promoting the regeneration of white cell and treating the leukocytopenia caused by chemicotherphy or radiotherapy is prepared from ginseng, atractylodes rhizome, rice vinegar and green alum through baking and pulverizing ginseng and atractylodes rhizome to obtain particles less than 120 meshes, mixing, calcining and pulverizing others to obtain particles less than 12 meshes, and mixing. Its advantages are high curative effect and no toxic by-effect.
Description
Technical field
This invention belongs to the Chinese medicine class, relates in particular to the leukopenia that treatment causes by radiotherapy, chemotherapy and the Chinese medicine (the white spirit of ginseng) and the manufacture method of agranulocytosis.
Background technology
Radiotherapy, chemotherapy are generally acknowledged by medical circle already as one of main method for the treatment of malignant tumor.But the serious toxic and side effects of bringing after radiotherapy, the chemotherapy, as nausea and vomiting, anorexia, oral cavity and esophageal ulcer etc., make the patient be difficult to stand and adhere to, the leukopenia and the agranulocytosis that cause of particularly radiotherapy, chemotherapy wherein, this serious toxic and side effects, so far still fail to solve, the patient often is forced to end to put, chemotherapy treatment, has therefore influenced curative effect and patient's life span greatly.How to urge leukocyte increasing, become a very important problem finishing radiotherapy, chemotherapy regimen for the patient.
The leukopenia that radiotherapy, chemotherapy cause, can cause severe infections, even cause death, to this serious consequence, use CSF (gene recombinaton granulocyte colony-stimulating factor) to impel hemopoietic granulocyte differentiation and proliferation clinically usually, stimulating granulocyte to grow up discharges, the granulocyte of blood around increasing, the control severe infections causes the reduction mortality rate to reach, use its curative effect of CSF reliable, but following shortcoming is arranged: 1) to M
3Type leukaemic can not use; 2) certain side effect is arranged, can not use as allergy sufferers; 3) be injection-type in the use, can bring misery to the patient; 4) most scholars think leukemia not the effector should not use promote the growth effect because CSF juvenile white cell to Leukemia Patients equally also has, can cause leukemia relapse or increase the weight of the state of an illness.
Summary of the invention
Purpose of the present invention is exactly in order to address the above problem, and a kind of short leukogenic Chinese medicine and manufacture method are provided.
A kind of short leukogenic Chinese medicine is characterized in that: by weight, made by Radix Ginseng 1-5 part, Rhizoma Atractylodis 2-6 part, rice vinegar 3-7 part, ferrosisuifas crudus 8-12 part.
The manufacture method of above-mentioned Chinese medicine is characterized in that: by above proportioning, get Radix Ginseng, Rhizoma Atractylodis earlier, after the purification, dry, be ground into the following granule of 120 orders; Ferrosisuifas crudus is mixed with rice vinegar, after the calcination, be ground into the following granule of 120 orders, mix with aforementioned particles again and mix thoroughly.
Produced according to the method described above Chinese medicine (the white spirit of ginseng) has the recovery of the marrow function of promotion and strengthens hemopoietic function, has the short rapidly leukocytic effect that rises, to better curative effect being arranged because of the concurrent severe infections of leukopenia, heating, also can control rapidly and cure infection, make body temperature recover normal naturally.To because of the bone marrow depression of putting, chemotherapy causes, cause erythrocyte to reduce and thrombocytopenia, the patient who presents serious anemia and bleeding clinically, have curative effect equally, can make erythrocyte, hemoglobin, platelet increase sharply, anemia and bleeding are eliminated, increase the oxygen content of blood, the patient is had rosy cheeks, breathe freely suitablely, muscle power strengthens.
Radiotherapy, chemotherapy take simultaneously Chinese medicine provided by the invention can make put, patients undergoing chemotherapy finishes chemotherapy regimen smoothly, thereby improve curative effect, to Leukemia Patients particularly remarkable because of leukopenia and the agranulocytosis that chemotherapy causes.
Chinese medicine provided by the invention has the effect of human body immunity improving power.
Chinese medicine provided by the invention has no side effect, and is oral capsule in the use, and determined curative effect is reliable, and no pain can replace the use of CSF.
The specific embodiment
By weight, get Radix Ginseng 100 grams, Rhizoma Atractylodis 500 grams, rice vinegar 500 grams, ferrosisuifas crudus 900 grams, earlier Radix Ginseng, Rhizoma Atractylodis are purified, dry, be ground into the following granule of 120 orders; Again ferrosisuifas crudus is mixed with rice vinegar, after the calcination, be ground into the following granule of 120 orders, mix to mix thoroughly promptly with aforementioned particles then and make.
The above-mentioned Chinese medicine of making is made honeyed pill or tablet or capsule, make every honeyed pill or tablet or capsule contain 525 milligrams in above-mentioned medicated powder, packing gets final product.
The zoopery of doing through Hong Kong Chinese University: give mice feed every day " the white spirit of ginseng " 5mg, after three days, measure the expression character of different mouse spleen cell mRNA (information nucleic acid), found that: the interleukin-11-α of experimental mouse (1L-1 alpha) exceeds four times than matched group, interleukin-11 3 (1L-13) exceeds three times than matched group, and stem cell factor (SCF) exceeds twice than matched group.
The biologic activity of interleukin-11 (1L-1): 1) promote thymocyte cell, T cell activation propagation and differentiation; 2) enhanced CT L (cytotoxic T lymphocyte) and NK's (natural killer cell) is lethal; 3) collaborative 1L-4 stimulates B cell proliferation, the generation of differentiation and immune globulin (1g); 4) collaborative CSF promotes hemopoietic function; 5) stimulate stem cell to produce stem cell factor (S.C.F).
The biologic activity of interleukin-11 3 (1L-13); 1) stimulate B cell proliferation and CD23 to express, induce the B cell produce immunoglobulin (1gM, 1gG, 1gE); 2) induce large granular lymphocyte (L.G.L) to produce interferon r (IFN-r); 3) suppressing monokaryon---the struvite cytokine of macrophage produces.
From above-mentioned zoopery, confirm the effect that " the white spirit of ginseng " has human body immunity improving power really.Put, chemotherapy takes " ginseng white spirit " clinical observation finding simultaneously:
1) can obviously alleviate gastrointestinal reaction, eliminate nausea and vomiting, appetite strengthening makes weight increase, and body constitution strengthens.
2) generation of the routed soup of control oral cavity and esophagus, the original oral ulcer of patient also can heal rapidly.
3) significantly reduce the incidence rate of alopecia.
Clearly, put, the chemotherapy patients proves in the clinical observation of taking " ginseng white spirit ", because immunocompetence improves, resistance strengthens, and puts, the toxic and side effects of chemotherapy just greatly reduces, and health status is significantly improved, the life quality obviously improves, and helps further putting, the enforcement of chemotherapy regimen.
Claims (2)
1, a kind of short leukogenic Chinese medicine is characterized in that: by weight, made by Radix Ginseng 1-5 part, Rhizoma Atractylodis 2-6 part, rice vinegar 3-7 part, ferrosisuifas crudus 8-12 part.
2, the manufacture method of Chinese medicine according to claim 1 is characterized in that: by above proportioning, get Radix Ginseng, Rhizoma Atractylodis earlier, after the purification, dry, be ground into the following granule of 120 orders; Ferrosisuifas crudus is mixed with rice vinegar, after the calcination, be ground into the following granule of 120 orders, mix with aforementioned particles again and mix thoroughly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01127787 CN1281224C (en) | 2001-08-28 | 2001-08-28 | Cinese medicine increasing leucocyte and preparation thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01127787 CN1281224C (en) | 2001-08-28 | 2001-08-28 | Cinese medicine increasing leucocyte and preparation thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1406602A true CN1406602A (en) | 2003-04-02 |
| CN1281224C CN1281224C (en) | 2006-10-25 |
Family
ID=4667701
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01127787 Expired - Fee Related CN1281224C (en) | 2001-08-28 | 2001-08-28 | Cinese medicine increasing leucocyte and preparation thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1281224C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7240369B2 (en) | 2002-05-01 | 2007-07-03 | Prolific Technology Inc. | Plug and play device and access control method therefor |
| CN107510821A (en) * | 2017-10-27 | 2017-12-26 | 刘萍 | A kind of medicine for treating leukopenia and preparation method thereof |
-
2001
- 2001-08-28 CN CN 01127787 patent/CN1281224C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7240369B2 (en) | 2002-05-01 | 2007-07-03 | Prolific Technology Inc. | Plug and play device and access control method therefor |
| CN107510821A (en) * | 2017-10-27 | 2017-12-26 | 刘萍 | A kind of medicine for treating leukopenia and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1281224C (en) | 2006-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU773546B2 (en) | Herbal extract composition and method with immune-boosting capability | |
| CN103505679B (en) | Drug for treating blood diseases, preparation method, and applications thereof | |
| CN1733136A (en) | Medicine for invigorating qi and nourishing blood comprising donkey-hid gelatin and angelica and process for preparing the same | |
| CN102961636B (en) | Pure traditional Chinese medicine composition for treating poultry infectious bursal disease and preparation method thereof | |
| CN1281224C (en) | Cinese medicine increasing leucocyte and preparation thereof | |
| CN1177598C (en) | Medicine for eliminating side effect of radiotherapy and chemotherapy to treat malignant tumor and its prepn | |
| TW201800099A (en) | The pharmaceutical composition for decreasing the side effects of cancer drug, and manufacturing method and uses thereof | |
| CN1381265A (en) | Medicine for treating cholecystitis and its preparing process | |
| Li et al. | Effects of traditional Chinese herbal medicines on blood cell count and immunity in chickens | |
| CN1376472A (en) | Medicine for treating aplastic anemia and its preapring process | |
| CN100352471C (en) | Medication for curing secondary anemia, iron deficiency anemia and preparation method | |
| CN117357627B (en) | Composite medicine for improving body immunity of poultry and preparation method and application thereof | |
| CN115317554B (en) | Traditional Chinese medicine composition for treating neutrophil deficiency with fever after chemotherapy and preparation method thereof | |
| CN1308940A (en) | Application and preparing process of nm-class biological medical stone powder | |
| CN1186036C (en) | Diabetes treating medicine and its prepn | |
| CN102475825A (en) | Spleen-tonifying and blood-enriching pill | |
| CN1273172C (en) | Medicine for treating chronic colonitis | |
| CN102475880A (en) | Qi-benefiting and blood-nourishing tablets | |
| CN102793896A (en) | Membranous milkvetch root and pilose Asiabell root tablet | |
| CN104906542A (en) | Traditional Chinese medicine composition for treating canine coronavirus infection and preparation method of traditional Chinese medicine composition | |
| CN1135999C (en) | Medicine for curing chicken disease of respiratory tract | |
| CN114588214A (en) | Composition and granules for improving bone marrow suppression after chemotherapy and preparation method | |
| CN1217924A (en) | Medicine for blood generation and preparing method | |
| CN1183288A (en) | Yiai pill (powder) and method for manufacturing same | |
| CN101297879A (en) | Interferon Chinese medicament inducer composition for treating avian virus disease and preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Cheng Hairong Document name: Notification of registration |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Cheng Hairong Document name: Notice of patent for invention |
|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Cheng Hairong Document name: Notification to Pay the Fees |
|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Cheng Hairong Document name: Resumption of patent approval decision |
|
| DD01 | Delivery of document by public notice |
Addressee: Cheng Hairong Document name: Notification to Pay the Fees |
|
| DD01 | Delivery of document by public notice |
Addressee: Cheng Hairong Document name: Notification of Termination of Patent Right |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20061025 Termination date: 20110828 |